Growth Metrics

Evaxion A (EVAX) EBITDA (2022 - 2026)

Evaxion A filings provide 5 years of EBITDA readings, the most recent being -$3.8 million for Q1 2026.

  • On a quarterly basis, EBITDA rose 1.27% to -$3.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$9.0 million, a 42.94% increase, with the full-year FY2025 number at -$9.2 million, up 37.32% from a year prior.
  • EBITDA hit -$3.8 million in Q1 2026 for Evaxion A, up from -$4.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $3.0 million in Q3 2025 to a low of -$6.5 million in Q4 2022.
  • Median EBITDA over the past 5 years was -$4.4 million (2024), compared with a mean of -$4.5 million.
  • Biggest five-year swings in EBITDA: decreased 8.55% in 2024 and later skyrocketed 274.58% in 2025.
  • Evaxion A's EBITDA stood at -$6.5 million in 2022, then surged by 33.12% to -$4.4 million in 2023, then increased by 7.79% to -$4.0 million in 2024, then decreased by 0.7% to -$4.1 million in 2025, then grew by 5.75% to -$3.8 million in 2026.
  • The last three reported values for EBITDA were -$3.8 million (Q1 2026), -$4.1 million (Q4 2025), and $3.0 million (Q3 2025) per Business Quant data.